Travere Therapeutics, Inc. (TVTX): Operating Income
-$62.82M
Year ended 2025-12-31
-$40.46M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$62.82M | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$323.83M | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$388.14M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$319.81M | n/m | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | -$199.43M | n/c | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | -$176.16M | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$137.36M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$80.04M | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$53.79M | n/m | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | -$58.21M | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | -$50.75M | n/m | 2018-07-06, From 2015-01-01 |
| 2014-12-31 | -$79.81M | n/m | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | -$24.77M | n/m | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | -$30.26M | n/a | 2015-07-09, From 2012-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | -$62.82M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $24.74M | +23.1% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$523.41M | n/m |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | -$22.14M | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$229.43M | n/m |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | -$39.16M | n/m |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $44.69M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $163.75M | -1.9% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$40.98M | n/m |
Compare TVTX, NATR, BBIO, MIRM side by side · Screen every company in Pharmaceutical Preparations ↗